The Biden administration issued a proposed rule through the Centers for Medicare and Medicaid Services that aims to increase transparency of prescription drug costs and managed care plan operations for Medicaid enrollees.
It would do this by implementing a new drug price verification survey tool and requiring the inclusion of drug...